<pre id="pnefw"></pre>

    <th id="pnefw"><option id="pnefw"></option></th>
    <object id="pnefw"></object>
  • <strike id="pnefw"></strike>

      About Zein

      Zein Biotechnology Co., Ltd., founded in 2001, is a national high-tech enterprise engaged in the construction of a full-life cycle management service system for drugs. We take MAH (Marketing Authorization Holder) as the core to support the registration and marketing of MAH drugs and commercial delivery with the compliance management and key technical service capabilities for the whole process of drug development, manufacturing, transaction promotion and post-marketing studies of drugs.
      After 20 years of development, we have been approved to establish the “Chongqing Chiral Drugs Engineering Technology Research Center”, “Chongqing New Drug Design Engineering Technology Research Center” and “Chongqing Postdoctoral Research Workstation”. We established the national-level “Drug Advanced Manufacturing Technology National and Local Joint Engineering Research Center” together with Chongqing University. At present, the industrial achievements include 33 new drug certificates, 51 production approvals, 11 foreign invention patents (including 2 in the United States, 2 in Europe, 1 in Japan, 2 in South Korea and 1 in India) and 36 domestic invention patents.
      We have built a R&D platform consisting of Liangjiang Medicine, Liujiang Pharma, Lanjiang Pharmaceutical and a clinical test research platform represented by Gerui Clinical Research Center Co., Ltd. (a Phase BE/I clinical research center that meets the GCP standards of the National Medical Products Administration) to provide integrated services for drug development and drug clinical research. We have built a CMO industrial service platform with our Changshou API Production Base and Jinfeng Preparations Production Base as the core, both of which were built in accordance with the new Chinese GMP, international cGMP and the latest safety and environmental standards. Changshou API Production Base covers an area of 82,000 square meters, and Jinfeng Preparations Production Base covers an area of 49,000 square meters. The capacity of API exceeds one hundred tons, and the preparations production lines cover normal-release and sustained-release capsules, granules, tablets and other dosage forms....

      View details

      Products and servicesProducts and services